Nifty

:

24273.80

Sensex

:

80334.81

-140.60 (-0.58%)
-411.97 (-0.51%)

Login

Nifty
Sensex

:
:

24273.80
80334.81

-140.60 (-0.58%)
-411.97 (-0.51%)

Sun Pharma Advanced Research Company Ltd.

Pharmaceuticals & Drugs - Global

Rating :

N/A

BSE: 532872 | NSE: SPARC

Watchlist

NSE BSE

159.45

06-Feb-2025

Open
High
Low
Previous Close

158.01
161.10
158.01
159.84

Volume
Traded Value (lacs)
52 Week High
52 Week Low

464855
743.10
258.00
109.30

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

4,614.70
N/A
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

4,697.78
N/A
-29.40

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-6.98
-0.33
-18.05

EBITDA CAGR (%)

10 Years
5 Years
3 Years

27.67
5.43
16.68

PAT CAGR (%)

10 Years
5 Years
3 Years

25.66
4.44
24.03

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

33.14
33.14
33.14

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-12.71
-12.71
-12.71

Earnings Forecasts:

Description 2024 2025 2026 2027
Adj EPS -11.96
P/E Ratio
Revenue 76
EBITDA -404
Net Income -388
ROA -59
P/B Ratio 54.33
ROE -121.73
FCFF -434.93
FCFF Yield -6.43

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 14.91 13.86 7.58% 12.86 21.18 -39.28% 16.81 23.95 -29.81% 16.56 47.69 -65.28%
Expenses 89.29 116.48 -23.34% 116.71 112.65 3.60% 111.93 126.13 -11.26% 124.08 137.26 -9.60%
EBITDA -74.38 -102.62 - -103.85 -91.47 - -95.12 -102.18 - -107.52 -89.57 -
EBIDTM -498.86% -740.40% -807.54% -431.87% -565.85% -426.64% -649.28% -187.82%
Other Income 0.19 6.39 -97.03% 0.04 8.49 -99.53% 1.56 10.19 -84.69% 4.40 10.73 -58.99%
Interest 2.77 0.26 965.38% 1.11 0.26 326.92% 0.52 0.26 100.00% 0.88 0.21 319.05%
Depreciation 2.75 3.16 -12.97% 2.77 3.18 -12.89% 2.76 3.10 -10.97% 2.69 2.94 -8.50%
PBT -79.71 -99.65 - -107.69 -86.42 - -96.84 -95.35 - -106.69 -81.99 -
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT -79.71 -99.65 - -107.69 -86.42 - -96.84 -95.35 - -106.69 -81.99 -
PATM -534.61% -718.98% -837.40% -408.03% -576.09% -398.12% -644.26% -171.92%
EPS -2.46 -3.07 - -3.32 -2.66 - -2.98 -2.94 - -3.29 -2.53 -

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 14.91 13.86 7.58% 12.86 21.18 -39.28% 16.81 23.95 -29.81% 16.56 47.69 -65.28%
Expenses 88.60 116.48 -23.94% 115.77 112.65 2.77% 110.17 126.13 -12.65% 122.39 137.26 -10.83%
EBITDA -73.69 -102.62 - -102.91 -91.47 - -93.36 -102.18 - -105.83 -89.57 -
EBIDTM -494.23% -740.40% -800.23% -431.87% -555.38% -426.64% -639.07% -187.82%
Other Income 0.19 6.39 -97.03% 0.04 8.49 -99.53% 1.56 10.19 -84.69% 4.40 10.73 -58.99%
Interest 2.80 0.26 976.92% 1.14 0.26 338.46% 0.56 0.26 115.38% 0.91 0.21 333.33%
Depreciation 3.14 3.16 -0.63% 3.16 3.18 -0.63% 3.14 3.10 1.29% 3.07 2.94 4.42%
PBT -79.44 -99.65 - -107.17 -86.42 - -95.50 -95.35 - -105.41 -81.99 -
Tax 0.07 0.00 0 0.16 0.00 0 0.40 0.00 0 0.38 0.00 0
PAT -79.51 -99.65 - -107.33 -86.42 - -95.90 -95.35 - -105.79 -81.99 -
PATM -533.27% -718.98% -834.60% -408.03% -570.49% -398.12% -638.83% -171.92%
EPS -2.45 -3.07 - -3.31 -2.66 - -2.96 -2.94 - -3.26 -2.53 -

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 61.14 75.55 238.78 137.25 252.96 76.81 182.87 78.26 181.02 161.28 155.74 Net Sales Growth -42.69% -68.36% 73.97% -45.74% 229.33% -58.00% 133.67% -56.77% 12.24% 3.56% Cost Of Goods Sold 24.88 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Gross Profit 36.26 75.55 238.78 137.25 252.96 76.81 182.87 78.26 181.02 161.28 155.74 GP Margin 59.31% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% Total Expenditure 442.01 479.34 452.84 324.00 387.93 386.83 334.16 320.87 303.72 224.48 190.83 Power & Fuel Cost - 6.14 5.75 4.62 4.60 5.14 5.08 4.92 4.67 4.49 4.78 % Of Sales - 8.13% 2.41% 3.37% 1.82% 6.69% 2.78% 6.29% 2.58% 2.78% 3.07% Employee Cost - 118.53 107.00 98.31 91.59 93.09 81.06 100.92 84.30 56.60 45.79 % Of Sales - 156.89% 44.81% 71.63% 36.21% 121.20% 44.33% 128.95% 46.57% 35.09% 29.40% Manufacturing Exp. - 140.23 180.31 134.27 209.78 30.47 17.81 31.79 29.39 26.42 17.96 % Of Sales - 185.61% 75.51% 97.83% 82.93% 39.67% 9.74% 40.62% 16.24% 16.38% 11.53% General & Admin Exp. - 207.41 154.91 84.39 78.49 251.32 221.40 181.18 180.29 131.88 119.37 % Of Sales - 274.53% 64.88% 61.49% 31.03% 327.20% 121.07% 231.51% 99.60% 81.77% 76.65% Selling & Distn. Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% Miscellaneous Exp. - 7.03 4.87 2.41 3.48 6.81 8.80 2.05 5.06 5.08 0.00 % Of Sales - 9.31% 2.04% 1.76% 1.38% 8.87% 4.81% 2.62% 2.80% 3.15% 1.89% EBITDA -380.87 -403.79 -214.06 -186.75 -134.97 -310.02 -151.29 -242.61 -122.70 -63.20 -35.09 EBITDA Margin -622.95% -534.47% -89.65% -136.07% -53.36% -403.62% -82.73% -310.01% -67.78% -39.19% -22.53% Other Income 6.19 29.47 10.88 6.84 5.41 9.76 13.51 4.94 13.72 2.94 3.03 Interest 5.28 1.66 7.63 13.33 10.65 2.67 0.09 0.12 1.82 2.16 0.22 Depreciation 10.97 12.13 11.77 10.16 10.92 9.48 7.55 8.18 8.24 7.58 7.24 PBT -390.93 -388.11 -222.58 -203.40 -151.14 -312.40 -145.43 -245.97 -119.04 -69.99 -39.52 Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Rate 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% PAT -390.93 -388.11 -222.58 -203.40 -151.14 -312.40 -145.43 -197.00 -119.04 -69.99 -39.52 PAT before Minority Interest -390.93 -388.11 -222.58 -203.40 -151.14 -312.40 -145.43 -197.00 -119.04 -69.99 -39.52 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -639.40% -513.71% -93.22% -148.20% -59.75% -406.72% -79.53% -251.73% -65.76% -43.40% -25.38% PAT Growth 0.00% - - - - - - - - - EPS -12.05 -11.96 -6.86 -6.27 -4.66 -9.63 -4.48 -6.07 -3.67 -2.16 -1.22

Description TTM Mar 24 Mar 23
Net Sales 61.14 75.55 238.78 Net Sales Growth -42.69% -68.36% Cost Of Goods Sold 24.88 0.00 0.00 Gross Profit 36.26 75.55 238.78 GP Margin 59.31% 100% 100% Total Expenditure 436.93 477.64 452.84 Power & Fuel Cost - 6.14 5.75 % Of Sales - 8.13% 2.41% Employee Cost - 141.84 107.00 % Of Sales - 187.74% 44.81% Manufacturing Exp. - 140.23 180.31 % Of Sales - 185.61% 75.51% General & Admin Exp. - 182.20 154.91 % Of Sales - 241.16% 64.88% Selling & Distn. Exp. - 0.00 0.00 % Of Sales - 0% 0% Miscellaneous Exp. - 7.23 4.87 % Of Sales - 9.57% 2.04% EBITDA -375.79 -402.09 -214.06 EBITDA Margin -614.64% -532.22% -89.65% Other Income 6.19 29.47 10.88 Interest 5.41 1.69 7.63 Depreciation 12.51 12.51 11.77 PBT -387.52 -386.83 -222.58 Tax 1.01 0.38 0.00 Tax Rate -0.26% -0.10% 0.00% PAT -388.53 -387.21 -222.58 PAT before Minority Interest -388.53 -387.21 -222.58 Minority Interest 0.00 0.00 0.00 PAT Margin -635.48% -512.52% -93.22% PAT Growth 0.00% - EPS -11.97 -11.93 -6.86

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 124.86 512.78 31.23 -168.25 -18.64 296.24 184.72 158.16 31.80 99.80 Share Capital 32.45 32.45 27.19 26.21 26.21 26.21 25.09 24.69 23.67 23.67 Total Reserves 92.40 480.32 -230.22 -194.46 -44.84 270.03 67.96 133.47 6.23 76.13 Non-Current Liabilities 117.59 138.41 77.43 164.59 55.85 7.20 11.98 10.36 10.02 9.72 Secured Loans 0.00 0.00 0.00 112.50 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 6.38 1.09 1.64 2.18 2.73 3.27 Long Term Provisions 6.05 8.14 8.15 8.63 10.23 6.11 10.34 8.18 7.30 6.37 Current Liabilities 243.89 178.95 171.43 233.35 235.36 95.04 116.11 108.03 124.84 37.15 Trade Payables 149.82 148.25 72.19 91.17 158.84 82.92 102.48 94.45 58.15 27.01 Other Current Liabilities 43.52 24.15 93.96 56.44 11.20 7.66 9.42 9.81 12.09 8.98 Short Term Borrowings 47.00 0.05 0.00 80.00 60.00 0.00 0.10 0.41 52.48 0.40 Short Term Provisions 3.55 6.49 5.28 5.75 5.31 4.46 4.10 3.35 2.12 0.77 Total Liabilities 486.34 830.14 280.09 229.69 272.57 398.48 312.81 276.55 166.66 146.67 Net Block 102.65 105.75 91.87 90.56 103.86 57.56 51.74 69.16 69.96 66.79 Gross Block 151.87 146.22 133.15 122.51 135.50 80.22 67.17 77.28 106.82 96.38 Accumulated Depreciation 49.22 40.47 41.28 31.95 31.64 22.66 15.44 8.12 36.86 29.58 Non Current Assets 239.93 375.16 208.93 166.58 205.38 141.09 137.59 118.27 98.88 83.46 Capital Work in Progress 43.79 27.00 26.37 5.23 32.07 24.13 3.27 1.47 0.87 0.02 Non Current Investment 0.42 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 67.67 64.80 67.83 70.64 69.24 59.29 82.48 47.45 27.99 16.55 Other Non Current Assets 25.40 177.61 22.87 0.15 0.20 0.12 0.10 0.19 0.07 0.09 Current Assets 246.41 454.96 71.15 63.11 67.19 257.38 175.22 158.28 66.59 62.93 Current Investments 1.80 290.90 11.66 6.43 8.49 210.58 107.57 9.65 0.00 0.00 Inventories 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Sundry Debtors 15.53 32.71 27.74 17.58 16.05 10.17 17.56 38.90 9.16 19.89 Cash & Bank 155.06 111.58 1.23 9.31 0.46 0.68 1.32 70.31 12.75 17.34 Other Current Assets 74.01 3.98 2.50 8.10 42.19 35.96 48.77 39.43 44.69 25.70 Short Term Loans & Adv. 54.43 15.80 28.02 21.70 39.33 33.39 46.73 37.48 43.35 24.27 Net Current Assets 2.52 276.02 -100.28 -170.24 -168.17 162.34 59.11 50.25 -58.24 25.79 Total Assets 486.34 830.12 280.08 229.69 272.57 398.47 312.81 276.55 166.65 146.67

Description Mar 24 Mar 23
Shareholder's Funds 125.76 512.78 Share Capital 32.45 32.45 Total Reserves 93.30 480.32 Non-Current Liabilities 122.97 138.41 Secured Loans 0.00 0.00 Unsecured Loans 0.00 0.00 Long Term Provisions 6.05 8.14 Current Liabilities 265.06 178.95 Trade Payables 142.29 148.25 Other Current Liabilities 61.88 24.15 Short Term Borrowings 47.00 0.05 Short Term Provisions 13.89 6.49 Total Liabilities 513.79 830.14 Net Block 107.53 105.75 Gross Block 157.14 146.22 Accumulated Depreciation 49.60 40.47 Non Current Assets 244.39 375.16 Capital Work in Progress 43.79 27.00 Non Current Investment 0.00 0.00 Long Term Loans & Adv. 67.67 64.80 Other Non Current Assets 25.40 177.61 Current Assets 269.39 454.96 Current Investments 1.80 290.90 Inventories 0.00 0.00 Sundry Debtors 15.53 32.71 Cash & Bank 155.33 111.58 Other Current Assets 96.72 3.98 Short Term Loans & Adv. 54.48 15.80 Net Current Assets 4.33 276.02 Total Assets 513.78 830.12

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity -429.43 -69.12 -208.23 -151.90 -210.81 -171.91 -182.77 -128.04 -44.21 -41.17 PBT -388.11 -222.58 -203.40 -151.14 -312.40 -145.43 -245.97 -119.04 -69.99 -39.52 Adjustment -11.33 6.99 16.67 48.75 9.44 -21.77 3.82 -1.14 9.25 4.73 Changes in Working Capital -25.88 141.11 -26.05 -47.88 102.02 -0.17 20.48 12.86 30.41 -3.74 Cash after chg. in Working capital -425.32 -74.48 -212.78 -150.26 -200.95 -167.38 -221.68 -107.32 -30.34 -38.53 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -4.11 5.37 4.54 -1.63 -9.86 -4.54 -10.08 -20.72 -13.87 -2.64 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 48.98 0.00 0.00 0.00 Cash From Investing Activity 391.11 -548.28 -29.17 1.56 155.35 -102.19 -104.62 -6.61 -13.08 53.00 Net Fixed Assets -22.44 -13.70 -31.78 39.83 -63.22 -33.91 8.31 28.94 -11.29 -8.66 Net Investments 288.68 -279.24 -5.23 2.06 202.09 -103.01 -97.92 -9.65 0.00 6.50 Others 124.87 -255.34 7.84 -40.33 16.48 34.73 -15.01 -25.90 -1.79 55.16 Cash from Financing Activity 42.80 616.76 229.32 159.28 55.46 274.25 224.01 194.25 50.55 -1.26 Net Cash Inflow / Outflow 4.48 -0.64 -8.08 8.95 0.00 0.15 -63.38 59.60 -6.74 10.57 Opening Cash & Equivalents 0.58 1.22 9.30 0.35 0.35 0.20 63.58 4.00 10.63 0.01 Closing Cash & Equivalent 5.06 0.58 1.22 9.30 0.35 0.35 0.20 63.58 4.00 10.63

Description Mar 24 Mar 23
Cash From Operating Activity -429.19 -69.12 PBT -386.83 -222.58 Adjustment -10.91 6.99 Changes in Working Capital -27.33 141.11 Cash after chg. in Working capital -425.08 -74.48 Interest Paid 0.00 0.00 Tax Paid -4.11 5.37 Other Direct Exp. Paid 0.00 0.00 Extra & Other Items 0.00 0.00 Cash From Investing Activity 391.53 -548.28 Net Fixed Assets -22.44 Net Investments 288.68 Others 125.29 Cash from Financing Activity 42.41 616.76 Net Cash Inflow / Outflow 4.74 -0.64 Opening Cash & Equivalents 0.58 1.22 Closing Cash & Equivalent 5.33 0.58

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 3.85 15.80 -7.47 -6.42 -0.71 11.30 3.71 6.41 1.21 4.18 ROA -58.96% -40.10% -79.80% -60.18% -93.11% -40.89% -66.85% -53.72% -44.68% -23.65% ROE -121.73% -143.72% 0.00% 0.00% -225.08% -74.72% -156.84% -127.40% -109.16% -33.17% ROCE -112.88% -69.44% -225.57% -254.10% -178.95% -59.95% -113.05% -94.66% -71.37% -31.74% Fixed Asset Turnover 0.51 1.71 1.07 1.96 0.71 2.48 1.08 1.97 1.59 1.70 Receivable days 116.55 46.20 60.25 24.26 62.28 27.67 131.66 48.45 32.87 56.11 Inventory Days 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Payable days 0.00 0.00 0.00 0.00 316.55 300.15 244.72 218.01 163.03 136.14 Cash Conversion Cycle 116.55 46.20 60.25 24.26 -254.27 -272.48 -113.05 -169.56 -130.16 -80.03 Total Debt/Equity 0.38 0.00 -0.37 -1.37 -3.59 0.01 0.02 0.02 1.94 0.04 Interest Cover -233.48 -28.15 -14.26 -13.19 -115.79 -1547.78 -1596.71 -64.41 -31.45 -180.04

Description Mar 24 Mar 23
Book Value (Rs.) 3.88 15.80 ROA -57.63% -26.81% ROE -121.28% -43.41% ROCE -112.35% -41.91% Fixed Asset Turnover 0.50 1.63 Receivable days 116.55 50.01 Inventory Days 0.00 0.00 Payable days 0.00 0.00 Cash Conversion Cycle 116.55 50.01 Total Debt/Equity 0.37 0.00 Interest Cover -227.27 -28.15

Top Investors:

sun pharmaceutical industries key employees benefit trust

lakshdeep investments & finance (p) ltd.

vijay mohanlal parekh

paresh mohanlal parekh

enam holdings pvt ltd

Annual Reports:

News Update:

Sun Pharma Adv. Res - Quarterly Results
10th Feb 2025, 19:56 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback